Skip to main content
Erschienen in: Diabetologia 4/2014

01.04.2014 | Article

Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study

verfasst von: Magnus T. Jensen, Peter Sogaard, Henrik U. Andersen, Jan Bech, Thomas F. Hansen, Søren Galatius, Peter G. Jørgensen, Tor Biering-Sørensen, Rasmus Møgelvang, Peter Rossing, Jan S. Jensen

Erschienen in: Diabetologia | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Heart failure is one of the leading causes of mortality in type 1 diabetes. Early identification is vitally important. We sought to determine the prevalence and clinical characteristics associated with subclinical impaired systolic and diastolic function in type 1 diabetes patients without known heart disease.

Methods

In this cross-sectional examination of 1,093 type 1 diabetes patients without known heart disease, randomly selected from the Steno Diabetes Center, complete clinical and echocardiographic examinations were performed and analysed in uni- and multivariable regression models.

Results

The mean (SD) age was 49.6 (15) years, 53% of participants were men, and the mean duration of diabetes was 25.5 (15) years. Overall, 15.5% (n = 169) of participants had grossly abnormal systolic or diastolic function, including 1.7% with left ventricular ejection fraction (LVEF) < 45% and 14.4% with evidence of long-standing diastolic dysfunction. In univariable models, clinical characteristics associated with abnormal myocardial function were: age (per 10 years), OR (95% CI) 2.1 (1.8, 2.4); diabetes duration (per 10 years), 1.7 (1.4, 1.9); systolic BP ≥ 140 mmHg, 2.7 (1.9, 3.8); diastolic BP ≥ 90 mmHg, 1.8 (1.0, 3.1); estimated (e)GFR < 60 ml min−1 1.73 m−2, 3.8 (2.5, 5.9); microalbuminuria, 2.0 (1.3, 3.0); macroalbuminuria, 5.9 (3.8, 9.3); proliferative retinopathy, 3.6 (2.3, 5.8); blindness, 10.1 (3.2, 31.6); and peripheral neuropathy, 3.8 (2.7, 5.3). In multivariable models only age (2.1 [1.7, 2.5]), female sex, (1.9 [1.2, 2.8]) and macroalbuminuria (5.2 [2.9, 10.3]) remained significantly associated with subclinical grossly abnormal myocardial function.

Conclusions/interpretation

Subclinical myocardial dysfunction is a common finding in type 1 diabetes patients without known heart disease. Type 1 diabetes patients with albuminuria are at greatly increased risk of having subclinical abnormal myocardial function compared with patients without albuminuria. Echocardiography may be particularly warranted in patients with albuminuria.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Soedamah-Muthu SS, Fuller JH, Mulnier HE et al (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29:798–804PubMedCrossRef Soedamah-Muthu SS, Fuller JH, Mulnier HE et al (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29:798–804PubMedCrossRef
2.
Zurück zum Zitat Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765PubMedCrossRef Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765PubMedCrossRef
3.
Zurück zum Zitat Lind M, Bounias I, Olsson M et al (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378:140–146PubMedCrossRef Lind M, Bounias I, Olsson M et al (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378:140–146PubMedCrossRef
4.
Zurück zum Zitat Mogensen UM, Jensen T, Køber L et al (2012) Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 61:1822–1830PubMedCentralPubMedCrossRef Mogensen UM, Jensen T, Køber L et al (2012) Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes 61:1822–1830PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Kim WY, Astrup AS, Stuber M et al (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115:228–235PubMedCrossRef Kim WY, Astrup AS, Stuber M et al (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115:228–235PubMedCrossRef
6.
Zurück zum Zitat Sato A, Tarnow L, Parving HH (1999) Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy. Diabetologia 42:76–80PubMedCrossRef Sato A, Tarnow L, Parving HH (1999) Prevalence of left ventricular hypertrophy in Type I diabetic patients with diabetic nephropathy. Diabetologia 42:76–80PubMedCrossRef
7.
Zurück zum Zitat Sato A, Tarnow L, Parving HH (1998) Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy. Diabetes Care 21:1534–1539PubMedCrossRef Sato A, Tarnow L, Parving HH (1998) Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy. Diabetes Care 21:1534–1539PubMedCrossRef
8.
Zurück zum Zitat Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595–602PubMedCrossRef Rubler S, Dlugash J, Yuceoglu YZ et al (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30:595–602PubMedCrossRef
9.
Zurück zum Zitat Yazici D, Yavuz DG, Toprak A et al (2013) Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease. Acta Diabetol 50:155–161PubMedCrossRef Yazici D, Yavuz DG, Toprak A et al (2013) Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease. Acta Diabetol 50:155–161PubMedCrossRef
10.
Zurück zum Zitat Halley CM, Houghtaling PL, Khalil MK et al (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087PubMedCrossRef Halley CM, Houghtaling PL, Khalil MK et al (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087PubMedCrossRef
11.
Zurück zum Zitat Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543–567PubMedCrossRef Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543–567PubMedCrossRef
12.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463PubMedCrossRef
13.
Zurück zum Zitat Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193PubMedCrossRef Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193PubMedCrossRef
14.
Zurück zum Zitat Unzek S, Popovic ZB, Marwick TH, Diastolic Guidelines Concordance Investigators (2011) Effect of recommendations on interobserver consistency of diastolic function evaluation. JACC Cardiovasc Imaging 4:460–467PubMedCrossRef Unzek S, Popovic ZB, Marwick TH, Diastolic Guidelines Concordance Investigators (2011) Effect of recommendations on interobserver consistency of diastolic function evaluation. JACC Cardiovasc Imaging 4:460–467PubMedCrossRef
15.
Zurück zum Zitat Mantha S, Roizen MF, Fleisher LA et al (2000) Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth Analg 90:593–602PubMedCrossRef Mantha S, Roizen MF, Fleisher LA et al (2000) Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth Analg 90:593–602PubMedCrossRef
16.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMedCrossRef
17.
Zurück zum Zitat Andersen AR, Christiansen JS, Andersen JK et al (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501PubMedCrossRef Andersen AR, Christiansen JS, Andersen JK et al (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501PubMedCrossRef
18.
Zurück zum Zitat Redfield MM, Jacobsen SJ, Burnett JC Jr et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202PubMedCrossRef Redfield MM, Jacobsen SJ, Burnett JC Jr et al (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202PubMedCrossRef
19.
Zurück zum Zitat Mogelvang R, Sogaard P, Pedersen SA et al (2009) Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 119:2679–2685PubMedCrossRef Mogelvang R, Sogaard P, Pedersen SA et al (2009) Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 119:2679–2685PubMedCrossRef
20.
Zurück zum Zitat Davies M, Hobbs F, Davis R et al (2001) Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358:439–444PubMedCrossRef Davies M, Hobbs F, Davis R et al (2001) Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358:439–444PubMedCrossRef
21.
Zurück zum Zitat Hillis GS, Møller JE, Pellikka PA et al (2004) Noninvasive estimation of left ventricular filling pressure by E/e′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367PubMedCrossRef Hillis GS, Møller JE, Pellikka PA et al (2004) Noninvasive estimation of left ventricular filling pressure by E/e′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43:360–367PubMedCrossRef
22.
Zurück zum Zitat Kuznetsova T, Herbots L, López B et al (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2:105–112PubMedCrossRef Kuznetsova T, Herbots L, López B et al (2009) Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2:105–112PubMedCrossRef
23.
Zurück zum Zitat From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef From AM, Scott CG, Chen HH (2010) The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. J Am Coll Cardiol 55:300–305PubMedCrossRef
24.
Zurück zum Zitat Von Bibra H, St John Sutton M (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53:1033–1045CrossRef Von Bibra H, St John Sutton M (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53:1033–1045CrossRef
25.
Zurück zum Zitat Di Bonito P, Moio N, Cavuto L et al (2005) Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diabet Med J Br Diabet Assoc 22:1720–1725CrossRef Di Bonito P, Moio N, Cavuto L et al (2005) Early detection of diabetic cardiomyopathy: usefulness of tissue Doppler imaging. Diabet Med J Br Diabet Assoc 22:1720–1725CrossRef
26.
Zurück zum Zitat Salem M, El Behery S, Adly A et al (2009) Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 10:513–521PubMedCrossRef Salem M, El Behery S, Adly A et al (2009) Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 10:513–521PubMedCrossRef
27.
Zurück zum Zitat Gul K, Celebi AS, Kacmaz F et al (2009) Tissue Doppler imaging must be performed to detect early left ventricular dysfunction in patients with type 1 diabetes mellitus. Eur J Echocardiogr 10:841–846PubMedCrossRef Gul K, Celebi AS, Kacmaz F et al (2009) Tissue Doppler imaging must be performed to detect early left ventricular dysfunction in patients with type 1 diabetes mellitus. Eur J Echocardiogr 10:841–846PubMedCrossRef
Metadaten
Titel
Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study
verfasst von
Magnus T. Jensen
Peter Sogaard
Henrik U. Andersen
Jan Bech
Thomas F. Hansen
Søren Galatius
Peter G. Jørgensen
Tor Biering-Sørensen
Rasmus Møgelvang
Peter Rossing
Jan S. Jensen
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 4/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3164-5

Weitere Artikel der Ausgabe 4/2014

Diabetologia 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.